In this week's edition we take a look at the Zuma effect, surprising ways the economy will change and deliver a sobering Covid-19 report card.
High level clouds. Warm.
It's a big deal for people seeking HIV-prevention drugs, who currently battle stigma and potentially wait months to get the medication.
Jeff Jonas says the new drug could help depressed people feel well "with just a two week course of treatment", similar to how antibiotics are used.
The shortage of skills in South Africa’s pharmaceutical industry makes it easier for collusion to take place in the healthcare sector, says a Department of Health official.
Generic medicine is expected to continue its growth trajectory in 2017, says the CEO of a pharmaceutical company.
Dis-Chem plans to start trading on the JSE as the pharmacy group looks to double its outlets in the next five to eight years.
Aspen Pharmacare has posted a gain in profit, beating expectations as the expansion of its international business outweighed the cost of imported materials.
Shares of Adcock Ingram have surged more than 4% in early trade on news that top shareholder Bidvest Group is looking to raise its stake in the drugmaker.
Pharmaceutical giant Pfizer is facing a wave of lawsuits by women who allege that the company knew about serious side effects of its anti-cholesterol drug.
AstraZeneca has raised its sales and earnings forecasts for the year, showing
resilience after seeing off a $118bn takeover approach from rival Pfizer.
British household goods firm Reckitt Benckiser has decided to spin off its pharmaceuticals division, after a strategic review.
Amazon has set its sights on the pharmacy market with the acquisition of tech-focused retailer PillPack, sending shock waves through the sector over prospects of disruption.
Many diverse threads in the experiences of Konji Sebati – she’s a medical doctor – are woven into the rich tapestry of her life, culminating in her position as CEO of the Innovative Pharmaceutical Association SA, writes Sue Grant-Marshall.
The Competition Commission announced it will investigate excessive pricing of cancer medication.
The Competition Tribunal has announced that it has approved – with conditions – the merger between Clicks and Netcare’s in-hospital “front shops”.
Despite the economic slump, Ascendis Health is relying on wealthy consumers and expansion into Spain to grow its profits. Finweek caught up with CEO, Dr Karsten Wellner.
South Africa's Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline to extend its foothold in Japan, a lucrative market for low-cost medicines.
Botox-maker Allergan has approached Salix Pharmaceuticals about a potential takeover that could scuttle Valeant Pharmaceuticals' hostile bid for Allergan.
Private equity firms are mulling over a $10bn plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, according to a report.
German chemicals and pharmaceuticals giant Bayer maker of Aspirin painkiller, has reported a 13% surge in its net profit in the Q2.
Swiss pharmaceutical giant Novartis says its net profits for the first half have shot up by 13%, and has stuck by its forecast of continued sales growth.
Cape TownMass Staffing ProjectsR400 000.00 - R600 000.00 Per Year
Cape TownTumaini ConsultingR720 000.00 - R960 000.00 Per Year
Western CapePlacement Point (Pty) Ltd
R 3 300 000
R 3 700 000
R 2 650 000
We subscribe to the Press Code.
You choose what you want
News24 on Android
Get the latest from News24 on your Android device.
Terms and Conditions
24.com Terms and Conditions - Updated April 2012
Creating your profile will enable you to submit photos and stories to get published on News24.
This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.